文献速递呼吸危重症与机械通气

机器学习模型识别ARDS亚型的验证与临床应用

Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis.
PubMed 文献 · Lancet Respir Med · 2022-01-10

本研究在EARLI(n=335)和VALID(n=452)两个观察性队列中,以潜类别分析(LCA)分型为金标准,验证了两种基于临床变量的机器学习分类器模型。主模型在EARLI的AUC为0·92(95%CI 0·90-0·95),在VALID为0·88(0·84-0·91)。在LUNG SAFE队列(n=2813)中,高炎症亚型患者90天死亡率高于低炎症亚型(57% vs 33%,p<0·0001),且亚型与PEEP策略存在显著治疗交互作用(p=0·041)。

要点

  • 仅用生命体征和实验室变量的分类器模型可准确判定ARDS亚型(AUC 0·88-0·92)
  • 高炎症亚型90天死亡率显著高于低炎症亚型(57% vs 33%)
  • 高炎症亚型患者接受高PEEP策略时90天死亡率较低(54% vs 62%)

核心结论

  • 仅使用临床变量的分类器模型可在观察性队列中准确判定ARDS亚型,并提供预后信息,有望指导包括PEEP应用在内的个体化治疗,但尚需前瞻性验证。

研究设计与样本

  • 观察性、多队列、回顾性研究,在EARLI(n=335)和VALID(n=452)两个观察性ARDS队列中验证两种机器学习临床分类器模型,以LCA衍生亚型为金标准。
  • 在LUNG SAFE跨国观察性ARDS队列(n=2813)中应用自定义分类器模型评估亚型预后价值及与PEEP策略的交互作用。

主要发现

  • 主分类器模型在EARLI的AUC为0·92(95%CI 0·90-0·95),在VALID为0·88(0·84-0·91)。
  • 仅使用电子健康记录自动提取的预测变量时,主模型性能与人工整理变量相似(AUC=0·88 [95%CI 0·81-0·94] vs 0·92 [0·88-0·97])。
  • LUNG SAFE中高炎症亚型90天死亡率高于低炎症亚型(414/725 [57%] vs 694/2088 [33%];p<0·0001)。
  • 亚型与PEEP策略存在显著治疗交互作用(p=0·041),高炎症亚型高PEEP组90天死亡率低于低PEEP组(169/313 [54%] vs 127/205 [62%])。
  • 低炎症亚型高PEEP组与低PEEP组90天死亡率相近(231/675 [34%] vs 233/734 [32%])。

关键数值与推荐

  • 亚型判定采用概率截断值0·5,并据此计算灵敏度、特异度和准确度。
  • 主模型仅含生命体征和实验室变量;次要模型在主模型基础上加入通气变量和人口学变量。
  • LUNG SAFE所用自定义分类器变量数少于主模型。

临床怎么用

  • 可借助仅需常规临床变量的分类器模型在床旁判定ARDS亚型,辅助风险分层与预后评估。
  • 对高炎症亚型患者,高PEEP策略可能带来生存获益,但该治疗交互结果需前瞻性验证后再用于临床决策。

局限性

  • 验证队列为观察性、回顾性设计,亚型判定以LCA为金标准。
  • PEEP策略与亚型的交互作用及个体化治疗建议尚需前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two acute respiratory distress syndrome (ARDS) subphenotypes (hyperinflammatory and hypoinflammatory) with distinct clinical and biological features and differential treatment responses have been identified using latent class analysis (LCA) in seven individual cohorts. To facilitate bedside identification of subphenotypes, clinical classifier models using readily available clinical variables have been described in four randomised controlled trials. We aimed to assess the performance of these models in observational cohorts of ARDS. METHODS: In this observational, multicohort, retrospective study, we validated two machine-learning clinical classifier models for assigning ARDS subphenotypes in two observational cohorts of patients with ARDS: Early Assessment of Renal and Lung Injury (EARLI; n=335) and Validating Acute Lung Injury Markers for Diagnosis (VALID; n=452), with LCA-derived subphenotypes as the gold standard. The primary model comprised only vital signs and laboratory variables, and the secondary model comprised all predictors in the primary model, with the addition of ventilatory variables and demographics. Model performance was assessed by calculating the area under the receiver operating characteristic curve (AUC) and calibration plots, and assigning subphenotypes using a probability cutoff value of 0·5 to determine sensitivity, specificity, and accuracy of the assignments. We also assessed the performance of the primary model in EARLI using data automatically extracted from an electronic health record (EHR; EHR-derived EARLI cohort). In Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE; n=2813), a multinational, observational ARDS cohort, we applied a custom classifier model (with fewer variables than the primary model) to determine the prognostic value of the subphenotypes and tested their interaction with the positive end-expiratory pressure (PEEP) strategy, with 90-day mortality as the dependent variable. FINDINGS: The primary clinical classifier model had an area under receiver operating characteristic curve (AUC) of 0·92 (95% CI 0·90-0·95) in EARLI and 0·88 (0·84-0·91) in VALID. Performance of the primary model was similar when using exclusively EHR-derived predictors compared with manually curated predictors (AUC=0·88 [95% CI 0·81-0·94] vs 0·92 [0·88-0·97]). In LUNG SAFE, 90-day mortality was higher in patients assigned the hyperinflammatory subphenotype than in those with the hypoinflammatory phenotype (414 [57%] of 725 vs 694 [33%] of 2088; p<0·0001). There was a significant treatment interaction with PEEP strategy and ARDS subphenotype (p=0·041), with lower 90-day mortality in the high PEEP group of patients with the hyperinflammatory subphenotype (hyperinflammatory subphenotype: 169 [54%] of 313 patients in the high PEEP group vs 127 [62%] of 205 patients in the low PEEP group; hypoinflammatory subphenotype: 231 [34%] of 675 patients in the high PEEP group vs 233 [32%] of 734 patients in the low PEEP group). INTERPRETATION: Classifier models using clinical variables alone can accurately assign ARDS subphenotypes in observational cohorts. Application of these models can provide valuable prognostic information and could inform management strategies for personalised treatment, including application of PEEP, once prospectively validated. FUNDING: US National Institutes of Health and European Society of Intensive Care Medicine.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Maddali MV, Churpek M, Pham T, et al. Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis. Lancet Respir Med. 2022. PMID: 35026177. doi:10.1016/S2213-2600(21)00461-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。